Sat.Jun 05, 2021

article thumbnail

Obesity represents a catastrophic failure of government policy, public health, and medicine

World of DTC Marketing

SUMMARY: Obesity has many causes, and while we would like to think the answer is as easy as people exercising more and eating less, it isn’t that simple. There is disagreement whether obesity is really considered a disease or a behavioral risk factor, similar to smoking, alcohol, and substance abuse that may lead to disease. Obesity is a multifactorial disease in which environmental conditions and several genes play an important role in developing this disease.

Medicine 193
article thumbnail

Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure

Pharma Mirror

Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for its non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, Netherlands and Finland.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alzheimer’s Drug Poses a Dilemma for the F.D.A.

NY Times

If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.

article thumbnail

Quantum holds the key to secure conference calls

Scienmag

The world is one step closer to ultimately secure conference calls, thanks to a collaboration between Quantum Communications Hub researchers and their German colleagues, enabling a quantum-secure conversation to take place between four parties simultaneously. The demonstration, led by Hub researchers based at Heriot-Watt University and published in Science Advances, is a timely advance, given […].

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

KalVista Pharmaceuticals Presents Phase 2 Clinical Data of Oral KVD900 for Treatment of HAE at C1-Inhibitor Deficiency & Angioedema Workshop

BioTech 365

KalVista Pharmaceuticals Presents Phase 2 Clinical Data of Oral KVD900 for Treatment of HAE at C1-Inhibitor Deficiency & Angioedema Workshop KalVista Pharmaceuticals Presents Phase 2 Clinical Data of Oral KVD900 for Treatment of HAE at C1-Inhibitor Deficiency & Angioedema Workshop … Continue reading →

40
article thumbnail

Cells/colony motion index of oral keratinocytes predicts epithelial regenerative capacity

Scienmag

The cells/colony motion index determined by non-invasive, quantitative measurements via optical flow algorithm is correlated with epithelial regenerative capacity of oral keratinocytes in mid-phase cultures, making it a reliable tool for quality control Credit: Niigata University Niigata, Japan – A comprehensive investigation on cells and colony motion offers new insight into the proliferative and epithelial […].

article thumbnail

Which pharmaceutical drugs have the most drug patents in Norway?

Drug Patent Watch

This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Norway? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 93